Entera Bio GAAP EPS of -$0.13 beats by $0.05, revenue of $0.07M misses by $0.02M

• Entera Bio press release (NASDAQ:ENTX): Q1 GAAP EPS of -$0.13 beats by $0.05.
• Revenue of $0.07M (-56.3% Y/Y) misses by $0.02M.
• As of March 31, 2022, Entera had cash and cash equivalents of $20.1 million, compared to $24.9 million as of December 31, 2021.
• Entera expects that the current cash is sufficient to fund the operations into the fourth quarter of 2022.